Glomerular extracellular matrix and growth factors in diffuse mesangial sclerosis

Pediatric Nephrology

Volumn 16, Issue 5, 2001, Pages 429-438

  Yang, Youxin ^a   Zhang, Shao Yu ^a   Sich, Mireille ^a   Béziau, Agnès ^a   Van Den Heuvel, Lambert P W J ^b   Gubler, Marie Claire ^a  

^a INSERM   (France)

^b RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

Chondroitin sulfate proteoglycan; Denys Drash syndrome; Diffuse mesangial sclerosis; Heparan sulfate proteoglycan; Platelet derived growth factor A; Transforming growth factor 1; WT1

Indexed keywords

AGRIN; ANTIGEN; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 4; COLLAGEN TYPE 5; COLLAGEN TYPE 6; FIBRONECTIN; GAMMA CHAIN; GENE PRODUCT; GLYCOPROTEIN; GROWTH FACTOR; HEPARAN SULFATE; LAMININ; PERLECAN; PLATELET DERIVED GROWTH FACTOR A; PROTEOCHONDROITIN SULFATE; PROTEOHEPARAN SULFATE; SCLEROPROTEIN; TENASCIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; WT1 PROTEIN;

ALPHA CHAIN; ARTICLE; BETA CHAIN; BIOACCUMULATION; CHEMICAL COMPOSITION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DENYS DRASH SYNDROME; DISEASE COURSE; DISEASE SEVERITY; DOWN REGULATION; EXTRACELLULAR MATRIX; FEMALE; GENE MUTATION; GLOMERULOSCLEROSIS; GLOMERULUS; GLOMERULUS BASEMENT MEMBRANE; HUMAN; HUMAN TISSUE; KIDNEY FAILURE; MALE; MESANGIUM CELL; MORPHOLOGY; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; PROTEINURIA; REGULATORY MECHANISM; STAGING; SUBENDOTHELIUM; TISSUE DISTRIBUTION;

CHILD; CHILD, PRESCHOOL; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; FEMALE; FIBRONECTINS; FLUORESCENT ANTIBODY TECHNIQUE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; GROWTH SUBSTANCES; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOHISTOCHEMISTRY; INFANT; KIDNEY FAILURE, CHRONIC; KIDNEY GLOMERULUS; LAMININ; MALE; MEMBRANE GLYCOPROTEINS; PROTEOGLYCANS;

EID: 0035009938     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004670100563     Document Type: Article

References (40)

1. Habib R, Gubler MC, Antignac C, Gagnadoux MF (1993) Diffuse mesangial sclerosis: a congenital glomerulopathy with nephrotic syndrome. Adv Nephrol 22:43-56
2. Drash A, Sherman F, Hartmann W, Blizzard RMA (1970) A syndrome of pseudohermaphroditism, Wilms' tumor, hypertension, and degenerative renal disease. J Pediatr 76:585-593
3. Pelletier J, Bruening W, Kashtan CE, Mauer SM, Manivel JC, Striegel JE, Houghton DC, Junien C, Habib R, Fouser L, Fine RN, Silverman BL, Haber DA, Housman D (1991) Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 67:437-447
4. Little M, Wells C (1997) A clinical overview of WT1 gene mutations. Hum Mutat 9:209-225
5. Jeanpierre C, Denamur E, Henry I, Cabanis MO, Luce S, Cécille A, Elion J, Peuchmaur M, Loirat C, Niaudet P, Gubler MC, Junien C (1998) Identification of constitutional WT1 mutations in patients with isolated diffuse mesangial sclerosis (IDMS) and analysis of genotype-phenotype correlations using a computerized mutation database. Am J Hum Genet 62:824-833
6. Timpl R (1989) Structure and biochemical activity of basement membrane proteins. Eur J Biochem 180:487-502
7. Kleppel M, Santi PA, Cameron JD, Wieslander J, Michael AF (1989) Human tissue distribution of novel basement membrane collagen. Am J Pathol 134:813-825
8. Van den Born J, Van den Heuvel LP, Bakker MA, Veerkamp JH, Assmann KJ, Weening JJ, Berden JH (1993) Distribution of GBM heparan sulfate proteoglycan core protein and side chains in human glomerular diseases. Kidney Int 43:454-463
9. McCarthy KJ, Bynum K, St John PL, Abrahamson DR, Couchman JR (1993) Basement membrane proteoglycans in glomerular morphogenesis: chondroitin sulfate proteoglycan is temporally and spatially restricted during development. J Histochem Cytochem 41:401-414
10. Miner JH, Patton BL, Lentz SI, Gilbert DJ, Snider WD, Jenkins NA, Copeland NG, Sanes JR (1997) The laminin α chains: expression, developmental transitions and chromosomal locations of α1-5, identification of heterotrimeric laminins 8-11, and cloning of a novel α3 isoform. J Cell Biol 137:685-701
11. Groffen AJ, Ruegg MA, Dijkman H, Velden TJ van de, Buskens CA, Born J van den, Assmann KJ, Monnens LA, Veerkamp JH, Heuvel LP van den (1998) Agrin is a major heparan sulfate proteoglycan in the human glomerular basement membrane. J Histochem Cytochem 46:19-28
12. Nerlich AG, Wiest I, Schleicher ED (1995). Localization of extracellular matrix components in congenital nephrotic syndromes. Pediatr Nephrol 9:145-153
13. Van den Heuvel LP, Westenend PJ, Van den Born J, Assmann KJ, Knoers N, Monnens LA (1995) Aberrant proteoglycan composition of the glomerular basement membrane in a patient with Denys-Drash syndrome. Nephrol Dial Transplant 10:2205-2211
14. Johansson C, Butkowski R, Wieslander J (1991) Characterization of monoclonal antibodies to the globular domain of collagen IV. Connect Tissue Res 25: 229-241
15. Ding J, Kashtan CE, Fan W, Kleppel MM, Sun MJ, Kalluri R, Nielson EG, Michael AK (1994) A monoclonal antibody marker for Alport syndrome identifies the Alport antigen as the alpha 5 chain of type IV collagen. Kidney Int 46:1504-1506
16. Foellmer HG, Madri JA, Furthmayr H (1983) Monoclonal antibodies to type IV collagen: probes for the study of structure and function of basement membranes. Lab Invest 48:639-649
17. Hessle H, Engvall E (1984) Type VI collagen: studies on its localization, structure and biosynthetic form with monoclonal antibodies. J Biol Chem 259:3955-3961
18. Hunter DD, Shah V, Merlie JP, Sanes JR (1989) A laminin-like adhesive protein concentrated in the synaptic cleft of the neuromuscular junction. Nature 338:229-233
19. Katz A, Fish AJ, Kleppel MM, Hagen SG, Michael AF, Butkowski RJ (1991) Renal entactin (nidogen): isolation, characterization and tissue distribution. Kidney Int 40:643-652
20. Van den Born J, Van den Heuvel LP, Bakker MA, Veerkamp JH, Assmann KJ, Berden JHM (1992) A monoclonal antibody against GBM heparan sulfate induces an acute selective proteinuria in rats. Kidney Int 41:115-123
21. Noonan DM, Hassel JR (1993) Perlecan, the large low-density proteoglycan of basement membranes: structure and variant forms. Kidney Int 43:53-60
22. Kanwar YS, Linker A, Farquhar MG (1980) Increased permeability of the glomerular basement membrane to ferritin after removal of glycosaminoglycans (heparan sulfate) by enzyme digestion. J Cell Biol 86:680-693
23. Jadresic LP, Filler G, Barratt TM (1991) Urine glycosaminoglycans in congenital and acquired nephrotic syndrome. Kidney Int 40:280-284
24. Vermylen C, Levin M, Mossman J, Barratt TM (1989) Reduced heparan sulfate content of glomerular basement membrane and increased urinary excretion in congenital nephrotic syndrome. Pediatr Nephrol 3:122-129
25. Van Bruggen MCJ, Kramers K, Hylkema MN, Born J van den, Bakker MAH, Assmann KJM, Smeenk RJT, Berden JHM (1995) Decrease of heparan sulfate staining in the glomerular basement membrane in murine lupus nephritis. Am J Pathol 146:753-763
26. Van den Heuvel LP, Van den Born J, Jalanko H, Schroder CH, Veerkamp JH, Assmann KJ, Berden JH, Holmberg C, Rapola J, Monnens LA (1992) The glycosaminoglycan content of renal basement membranes in the congenital nephrotic syndrome of the Finnish type. Pediatr Nephrol 6:10-15
27. Kestilä M, Lenkkeri U, Männikkö M, Lamerdin J, McCready P, Putaala H, Ruotsalainen V, Morita T, Nissinen M, Herva R. Kashtan CE, Peltonen L, Holmberg C, Olsen A, Tryggvason K (1998) Positionally cloned gene for a novel glomerular protein - nephrin - is mutated in congenital nephrotic syndrome. Mol Cell 1:1-20
28. Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, Haber DA. Rose EA, Krai A, Yeger H, Lewis WH, Jones C, Housman DE (1990) Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 60:509-520
29. Reddy JC, Morris JC, Wang J, English MA, Haber DA, Shi Y, Licht JD (1995) WT1-mediated transcriptional activation is inhibited by dominant negative mutant proteins. J Biol Chem 270:10878-10884
30. Vicanek C, Ferretti E, Goodyer C, Torban E, Moffett P, Pelletier J, Goodyer P (1997) Regulation of renal EGF receptor expression is normal in Denys-Drash syndrome. Kidney Int 52:614-619
31. Yang Y, Jeanpierre C, Dressier GR, Lacoste M, Niaudet P, Gubler MC (1999) WT1 and PAX-2 podocyte expression in Denys-Drash syndrome and isolated diffuse mesangial sclerosis. Am J Pathol 154: 181-192
32. Alpers CE, Hudkins KL, Ferguson M, Johnson RJ, Rutledge JC (1995) Platelet-derived growth factor A-chain expression in developing and mature human kidneys and in Wilms' tumor. Kidney Int 48:146-154
33. Johnson RJ, Raines EW, Floege J, Yoshimura A, Pritzl P, Alpers CE, Ross R (1992) Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor. J Exp Med 175:1413-1416
34. Gesualdo L, Pinzani M, Floriano JJ, Hassan MO, Nagy NU, Schena FP, Emancipator SN, Abboud HE (1991) Platelet-derived growth factor expression in mesangial proliferative glomerulonephritis. Lab Invest 65:160-167
35. Isaka Y, Fujiwara Y, Ueda N, Kaneda Y, Kamada T, Imai E (1993) Glomeruloscierosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived grow factor gene into the rat kidney. J Clin Invest 92:2597-2601
36. Okuda S, Languino LR, Ruoslahti E, Border WA (1990) Elevated expression of transforming growth factor-β and proteoglycan production in experimental glomerulonephritis. J Clin Invest 86:453-462
37. Sayers R, Kalluri R, Rodgers KD, Shield III CF, Meehan DT, Cosgrove D (1999) Role for transforming growth factor-β1 in Alport renal disease progression. Kidney Int 56:1662-1673
38. Kopp JB, Factor VM, Mozes M, Nagy P, Sanderson N, Böttinger EP, Klotman PE, Thorgeirsson SS (1996) Transgenic mice with increased plasma levels of TGF-β1 develop progressive renal disease. Lab Invest 74:991-1003
39. Akagi Y, Isaka Y, Arai M, Kaneko T, Takenaka M, Miriyama T, Kaneda Y, Ando A, Orita Y, Kamada T, Ueda N, Imai E (1996) Inhibition of TGF-beta 1 expression by antisense oligonucleotides suppressed extracellular matrix accumulation in experimental glomerulonephritis. Kidney Int 50:148-155
40. Isaka Y, Akagi Y, Kaneko T, Ando Y, Tsujie M, Sudo T, Ohno N, Border WA. Noble NA, Kaneda Y, Hori M, Imai E (1999) Gene therapy by transforming growth factor β-receptor-IgG Fc chimera suppressed extracellular matrix accumulation in experimental glomerulonephritis. Kidney Int 55:465-475